Key result
Early repatriation of stable STEMI patients post-PPCI is not linked to increased 30-day major events.
Why the study?
Repatriation of STEMI patients after PPCI is common in regional health care programs, but the short- and long-term safety of early repatriation in stable patients needed examination.
Does early repatriation prevent adverse clinical outcomes in stable STEMI patients after primary percutaneous coronary intervention?
Cohort (n=788)
Yes
Does early repatriation prevent adverse clinical outcomes in stable STEMI patients after primary percutaneous coronary intervention?
Effect estimate: OR 0.93 (95% CI 0.50-1.72)
p-value: p=0.82
Early repatriation of stable STEMI patients after primary PCI is safe and does not increase the risk of adverse cardiovascular events at 30 days or 1 year.
Early repatriation appears safe in this cohort of stable STEMI; leaves open need for randomized confirmation before practice change.
Abstract Background Repatriation of ST-segment elevation myocardial infarction (STEMI) patients after primary percutaneous coronary intervention (PPCI) is common in regional health care programs. We examined the short- and long-term safety of early repatriation after PPCI in stable STEMI patients. Methods Consecutive stable STEMI patients undergoing PPCI between 2016 to 2018 in the Fraser Health Authority were included. Outcomes were compared between early and nonrepatriated cohorts. Co-primary outcomes were a composite of death, myocardial infarction, congestive heart failure, and stroke at 30 days and 1 year. Logistic regression analyses were performed to determine association between early repatriation and outcomes, and to assess impact of transfer to cardiologist- vs internist-based care centres. Results A total of 788 patients were included, with 62% being repatriated early. Primary composite and individual outcomes rates were similar between both cohorts. Early repatriation was not an independent predictor of 30-day (odds ratio [OR] 0.93, 95% confidence interval [CI] 0.50-1.72; P = 0.82) or 1-year (OR 1.05, 95% CI 0.67-1.65; P = 0.8) primary outcome, or of 30-day (OR 1.35, 95% CI 0.41-4.47, P = 0.63) or 1-year (OR 1.03, 95% CI 0.44-2.40; P = 0.95) mortality. Among early repatriated patients, transfer to cardiologist- vs internist-based care centres was not an independent factor for 30-day (OR 1.07, 95% CI 0.45-2.54; P = 0.87) or 1-year (OR 1.17, 95% 0.55-2.50, P = 0.69) primary outcome. Conclusions Early repatriation of stable STEMI patients after PPCI appears to be safe based on short- and long-term outcomes, and transfer to internist- vs cardiology-based centres did not affect outcomes. After PPCI, early repatriation allows for redistribution of stable STEMI patients to lower-acuity settings across regional hospitals.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2024) conducted a cohort in Stable ST-segment elevation myocardial infarction (STEMI) (n=788). Early repatriation vs. Nonrepatriated care was evaluated on Composite of death, myocardial infarction, congestive heart failure, and stroke at 30 days (OR 0.93, 95% CI 0.50-1.72, p=0.82). Early repatriation of stable STEMI patients after PPCI was not associated with increased 30-day risk of death, MI, heart failure, or stroke (OR 0.93; 95% CI 0.50-1.72; P=0.82).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: